APA (7th ed.) Citation

Luo, F., Lu, F., Cao, J., Ma, W., Xia, Z., Zhan, J., . . . Zhang, L. (2022). HIF-1α inhibition promotes the efficacy of immune checkpoint blockade in the treatment of non-small cell lung cancer. Cancer letters, 531, 39-56. https://doi.org/10.1016/j.canlet.2022.01.027

Chicago Style (17th ed.) Citation

Luo, Fan, et al. "HIF-1α Inhibition Promotes the Efficacy of Immune Checkpoint Blockade in the Treatment of Non-small Cell Lung Cancer." Cancer Letters 531 (2022): 39-56. https://doi.org/10.1016/j.canlet.2022.01.027.

MLA (9th ed.) Citation

Luo, Fan, et al. "HIF-1α Inhibition Promotes the Efficacy of Immune Checkpoint Blockade in the Treatment of Non-small Cell Lung Cancer." Cancer Letters, vol. 531, 2022, pp. 39-56, https://doi.org/10.1016/j.canlet.2022.01.027.